TWC
SCPH

TD Waterhouse Canada’s scPharmaceuticals SCPH Stock Holding History

TD Waterhouse Canada’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-150
Closed -$1.27K – 1920
2023
Q4 		$1.27K Buy
+150
New +$859 ﹤0.01% 1539

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

TD Waterhouse Canada's SCPH Position: Q1 2024 in Review

TD Waterhouse Canada sold out of scPharmaceuticals (SCPH) in Q1 2024, closing a stake of 150 shares — an estimated $1.27K sold.

TD Waterhouse Canada first reported a position in SCPH in Q4 2023 and held it in 1 quarter. The position peaked at $1.27K in Q4 2023. 76 funds tracked by Wall St. Rank hold SCPH as of Q1 2024.

  • TD Waterhouse Canada reported no remaining scPharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • TD Waterhouse Canada sold 150 scPharmaceuticals shares in Q1 2024, an estimated $1.27K.
  • TD Waterhouse Canada first reported a position in scPharmaceuticals in Q4 2023 and held it in 1 quarter.
  • TD Waterhouse Canada's scPharmaceuticals position peaked at $1.27K in Q4 2023.
  • 76 funds tracked by Wall St. Rank held scPharmaceuticals as of Q1 2024.

Based on TD Waterhouse Canada's 13F filing for Q1 2024, filed 10 May 2024.